EPINEPHRINE INJECTION USP
HIKMA CANADA LIMITED
Quick answers
Is there a shortage of EPINEPHRINE INJECTION USP in Canada?
No. There is no current shortage of EPINEPHRINE INJECTION USP 1MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ADRENALIN
SEARCHLIGHT PHARMA INC
NOREPINEPHRINE BITARTRATE INJECTION USP
SANDOZ CANADA INCORPORATED
Other Products
ADRENALIN TOPICAL SOLUTION
SEARCHLIGHT PHARMA INC
EPIPEN
VIATRIS SPECIALTY LLC
EPIPEN JR
VIATRIS SPECIALTY LLC
DIN
02435810
Strength
1MG
Dosage Form
Solution
Route
Subcutaneous Intratracheal Intravenous Intramuscular
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from HIKMA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
9MG · DIN 02304341
200MG · DIN 02459906
0.6MG · DIN 02432196
0.4MG · DIN 02432188
100MG · DIN 02507668
0.05MG · DIN 02457059
2MG · DIN 02457075
0.2% · DIN 02515377
500MG · DIN 02437104
1G · DIN 02437112
10G · DIN 02437120
2G · DIN 02499096